ABCL vs ECL
Abcellera Biologics Inc (ABCL) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ABCL revenue for 2024-12-31 was $28.8M. Net income was -$162.9M. Revenue was down 24.2% from 2023-12-31 to 2024-12-31. ABCL currently screens at market cap $1.12B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ABCL currently screens at market cap $1.12B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ABCL and ECL stock pages for the full models.
Not investment advice.